SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-20-098064
Filing Date
2020-08-25
Accepted
2020-08-24 18:54:45
Documents
2
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2028901d1_sc13g.htm SC 13G 75554
2 EXHIBIT 99.1 tm2028901d1_ex99-1.htm EX-99.1 6338
  Complete submission text file 0001104659-20-098064.txt   83546
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Subject) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90656 | Film No.: 201129090
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 30 STAR ISLAND DRIVE MIAMI BEACH FL 33139
Business Address 30 STAR ISLAND DRIVE MIAMI BEACH FL 33139 212-808-7729
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G